 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
2008 | 2007 | 2006 | 2005 | 2004 |2003 | 2002 | 2001 | 2000 |
1999| 1998 | 1997| 1996 | 1995| 1994 | 1993 | 1992 | 1991 | 1990 |
1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 |
- Retail Health Facilities
FTC Staff Comment to Representative Elaine Nekritz of the Illinois General Assembly Regarding House Bill 5372 Concerning the Regulation of Retail Health Facilities (June 2008) (V080013)
- Certificate of Need
Prepared Statement of the Federal Trade Commission Before the Florida State Senate Regarding Florida Certificate of Need Laws (April 2008) (V080009) - Collective Bargaining for Home Health Care Workers
FTC Staff Comment to The Honorable William J. Seitz, Senator, State of Ohio Senate, Regarding Ohio Executive Order 2007-23S, Establishing Collective Bargaining for Home Health Care Workers (February 2008) (V080001) - Certificate of Need
FTC Testimony for the Alaska House of Representatives Regarding Alaska Certificate of Need Laws (February 2008) (V080007)
- Health Care, Physician Collective Bargaining
FTC Staff Comment to the Puerto Rico House of Representatives Regarding Senate Bill 2190 Concerning Health Care Collective Bargaining (February 2008) (V080003)
- Limited Service Clinics
FTC Staff Comment Before the Massachusetts Department of Public Health Concerning Proposed Regulation of Limited Service Clinics, (October 2007) (V070015)
- Pharmacy Benefit Managers
FTC Staff Comments to Virginia House of Delegates concerning Virginia House Bill No. 945 to Regulate the Contractual Relationship Between Pharmacy Benefit Managers and Health Benefit Plans and Pharmacies (October 2006) (V060018)
- Medical Privacy
FTC Staff Comment to the Honorable Barbara S. Matthews Concerning California Senate Bill 401, To Amend the California Confidentiality of Medical Information Act (January 2006) (V050020)
- Pharmaceuticals
FTC Comment to the Food and Drug Administration Concerning Response to Citizen Petition by IVAX Pharmaceuticals Relating to Generic Drug Application (Apr. 2005) (V050006) - Optometry
FTC Staff Comment to the Honorable Harry R. Purkey Concerning Virginia H.B. 2518, H.B. 160, and S.B. 272 Relating to the Practice of Optometry (Mar. 2005) (V050004) - Pharmacy Benefit Managers
FTC Staff Comment to the Honorable Richard L. Brown Concerning North Dakota H.B. 1332 to Regulate the Contractual Relationship Between Pharmacy Benefit Managers and Covered Entities (Mar. 2005) (V050003)
- Contact Lenses
The Strength of Competition in the Sale of Rx Contact Lenses: An FTC Study (Feb. 2005) (V040010) - Intellectual Property, Pharmaceuticals
FTC Brief of Amicus Curiae in Teva Pharmaceuticals USA, Inc. v. Pfizer, Inc. Concerning Hatch-Waxman Infringement (Federal Circuit) (Feb. 2005) (P042112)
- Pharmacy Benefit Managers
FTC Comment to the Honorable Greg Aghazarian Concerning California A.B. 1960 Requiring Pharmacy Benefit Managers to Make Specified Disclosures to “Purchasers” and “Prospective Purchasers” Regarding Revenues and Drug Formularies (Sep. 2004) (V040027) - Antitrust, State Action
FTC Amicus Curiae Brief in Tennessee Hospital Co., LLC v. West Tennessee Healthcare, Inc. et al. Concerning Whether the Conduct of a Tennessee Private Act Hospital Authority is Exempt From the Antitrust Laws as State Action (Sixth Circuit) (Case No. 04-5387) (Jun. 4, 2004) (P042116) - Pharmaceuticals
Comments from FTC Staff to The Honorable Patrick C. Lynch, Attorney General, and The Honorable Juan M. Pichardo, Deputy Majority Leader, Senate, State of Rhode Island and Providence Plantations, Concerning the Competitive Effects of General Assembly Bills Containing "Freedom of Choice" and "Any Willing Provider" Provisions (April 8, 2004) (V040013)
- Optometry
Comments from FTC Staff to The Honorable Ward Crutchfield, Tennessee Senate Majority Leader, on Senate Bill 855, which would amend the portion of the Tennessee Code regulating the practice of Optometry (April 29, 2003)
- Hospitals
Response from FTC Staff to The Honorable Richard P. Ieyoub, Attorney General of the State of Louisiana, concerning the potential effect of Tenet Healthcare Corporation's proposed purchase of Slidell Memorial Hospital (April 1, 2003) (V030008)
- Physician Collective Bargaining
Response from FTC Staff to The Honorable Dennis Stapleton, Ohio House of Representatives, concerning House Bill 325, which would permit competing health care providers to engage in collective bargaining with health plans over fees and other contract terms (October 16, 2002) (V020017)
- Contact Lenses
Comments of FTC Staff to the Connecticut Board of Examiners for Opticians concerning the declaratory ruling proceeding on the interpretation and applicability of various statutes and regulations concerning the sale of contact lenses (March 27, 2002)
- Physician Collective Bargaining
Statement of FTC Staff to The Committee on Labor and Commerce, Alaska House of Representatives, concerning the threat of consumer harm resulting from physician collective bargaining under Alaska Senate Bill 37 (March 22, 2002)
- Physician Collective Bargaining
Comments from FTC Staff to The Honorable Brad Benson, State of Washington House of Representatives, concerning Washington House Bill 2360, which would allow physicians and other health care providers to engage in collective bargaining with health plans over a variety of contract terms and conditions, including fees they would receive for their services (February 8, 2002) (V020009)
- Physician Collective Bargaining
FTC Staff Comment Before the Alaska House of Representatives Concerning The Threat of Consumer Harm Resulting From Physician Collective Bargaining Under Alaska S.B. 37 (January 2002) (V020003)
- Physician Collective Bargaining
FTC Staff Comment to the Honorable Lisa Murkowski Concerning Alaska S.B. 37 to Authorize Competing Physicians to Engage in Collective Bargaining With Health Plans (January 2002) (V020003)
- Medical Privacy
Staff Comment Before the Department of Health and Human Services Concerning Medical Privacy Rules (February 2000) (V000001)
- Comments of FTC Staff to the Food and Drug Administration in the matter of 180-Day Marketing Exclusivity for Abbreviated New Drug Applications (November 4, 1999)
- Response of FTC Staff to the District of Columbia Office of the Corporation Counsel concerning the “Physicians Negotiation Act of 1999,” Bill No. 13-333, which would permit competing physicians to engage in collective bargaining with health plans (October 29, 1999)
- Response of FTC Staff to The Honorable O. Oliveira, Texas House of Representatives, concerning Senate Bill 1468, “An Act Relating to the Regulation of Physician Joint Negotiation,” which would permit competing physicians to jointly negotiate contractual terms with health plans under certain circumstances (May 13, 1999)
- Staff Comment Before the Food and Drug Administration Concerning Draft Guidance for Industry on Pharmaceutical Benefit Management Companies ( “PBMs”) (April 1998) (V980006)
- Staff Statement Before the Vermont Legislature Concerning Proposed Antitrust Immunity for Cooperative Agreements to Provide Health Care Services (October 20, 1994) (V950001)
- Response from FTC Staff to Ms. Katherine M. Carroll, Executive Director of the Medical Practitioner Review Panel in New Jersey, concerning one of the advertising regulations of the New Jersey Board of Medical Examiners (September 7, 1993)
- Response from FTC Staff to The Honorable William F. Cass, House of Representatives, State House, State of Massachusetts, concerning House Bill 1109, which would require that health plans offering prescription drug services contract with any provider willing to meet the plan’s terms (June 15, 1993)
- Response from FTC Staff to The Honorable John Smithee, House of Representatives, State of Texas, concerning legislative proposals that would require health plans to contract any provider willing to meet the plan’s terms (May 18, 1993)
- Response from FTC Staff to The Honorable Thomas C. Alexander, House of Representatives, State of South Carolina, concerning House Bill 3631, which would require that health plans offering prescription drug services contract with any provider willing to meet the plan’s terms (May 10, 1993)
- Statement from FTC Staff to the Joint Standing Committee on Business Legislation of the Maine House of Representatives, concerning L.D. 1151 which would amend Maine’s laws regarding optometry (May 3, 1993)
- Response from FTC Staff to Board Counsel, Division of Registration of Massachusetts, concerning certain proposed changes to the regulations of the Massachusetts Board of Registration in Optometry (April 20, 1993)
- Response from FTC Staff to The Honorable Roger A. Madigan, The Senate of Pennsylvania, concerning Senate Bill No. 505, which would require that health benefit plans offering prescription drug services contract with any provider willing to meet the plan’s terms (April 19, 1993)
- Response from FTC Staff to The Honorable E. Scott Garret, The State Assembly, New Jersey, concerning Assembly Bill No. 1221, which would require that health benefit plans offering prescription drug services contract with any provider willing to meet the plan’s terms (March 29, 1993)
- Response from FTC Staff to The Honorable Judy Baar Topinka, The Senate of Illinois, concerning S.B. 66, which would set up a demonstration program to test the feasibility of two kinds of alternative health care delivery systems, birth centers, and postsurgical recovery care centers (March 12, 1993)
- Response from FTC Staff to The Honorable Joseph P. Mazurek, Attorney General of the State of Montana, concerning the sunset review of an “any willing provider” law (February 4, 1993)
- Response from FTC Staff to the Legislative Audit Counsel, State of South Carolina, concerning the statutes and rules that regulate the health care professions (January 8, 1993)
- Statement from FTC Staff to the Joint Administrative Rule Review Committee of the Washington State Legislature, concerning recent amendments to the rules of the Washington State Board of Optometry that affect how optometrists deal with opticians concerning contact lens prescriptions (December 15, 1992)
- Response from FTC Staff to the Board of Chiropractic Examiners, State of Missouri, concerning a proposed rule to control how chiropractors may offer free or discounted services (December 11, 1992)
- Response from FTC Staff to The Honorable Robert J. Pavlovich, Montana House of Representatives, concerning proposed legislation concerning denturists (October 30, 1992)
- Response from FTC Staff to the Sunset Advisory Commission, State of Texas, concerning the review of the boards that regulate the health care professions (August 14, 1992)
- Response from FTC Staff to The Honorable Patrick Johnston, California State Senate, concerning Senate Bill 1986, which would limit the ability of health insurance companies to arrange for pharmacy services through contracts with non-resident pharmacy firms, by prohibiting exclusive contracts with them and by requiring that resident firms be allowed to contract to provide services on the same terms as non-resident firm (June 26, 1992)
- Response from FTC Staff to the Senate Legal Counsel, State of New Hampshire, concerning a bill to require any health maintenance organization that solicits bids for pharmacy providers to contract with any willing provider (March 17, 1992)
- Response from FTC Staff to the South Carolina Legislative Audit Council concerning statutes and regulations of the South Carolina Board of Pharmacy, Board of Medical Examiners, Board of Veterinary Medical Examiners, Board of Nursing, and Board of Chiropractic Examiners (February 26, 1992)
- Statement from FTC Staff to the Committee on Business Legislation, Maine House of Representatives, concerning a bill to amend Maine’s laws governing the practice of optometry (January 8, 1992)
- Response from FTC Staff to the Office of the Auditor General of the State of Florida concerning state statutes and regulations governing the activities of several licensed occupations (November 28, 1990)
- Response to The Honorable H. Craig Lewis, Senate of Pennsylvania, concerning Pennsylvania Senate Bill 675, entitled the “Pharmaceutical Services Freedom of Choice Act” (June 29, 1990)
- Response from FTC Staff to the Division of State Audit of the State of Tennessee concerning its review of statutes governing state agencies attached to the Tennessee Department of Health and Environment, including Chiropractic Examiners, Dentistry, Dispensing Opticians, Examiners in Psychology, Medical Examiners, Optometry, Osteopathic Examiners, Registration in Podiatry and Veterinary Medical Examiners (April 13, 1990)
- Response from FTC Staff to the Virginia Board of Pharmacy concerning proposed regulations for the dispensing and sale of prescription drugs by practitioners of the healing arts (November 27, 1989)
- Response from FTC Staff to New York State Senate, concerning Senate Bill No. 3094-A, which would prohibit, with certain exceptions, the dispensing of more than a 72-hour supply of prescription drugs by physicians and dentists (June 2, 1989)
- Response from FTC Staff to The Honorable John C. Bartley, Massachusetts House of Representatives, concerning Senate Bill 526, “An Act Providing For Accessibility To Pharmaceutical Services,” which would require prepaid health benefits programs that include coverage of pharmaceutical services, and provide those services through contracts with pharmacies, either to allow all pharmacies to provide services to program subscribers on the same terms, or to offer subscribers the alternative of obtaining covered pharmaceutical services from any pharmacy they choose (May 30, 1989)
- Response from FTC Staff to The Honorable Jack Jeffrey, Nevada State Legislature, concerning Senate Bill 86, which would prohibit a physical therapist from paying or receiving any fees in consideration for the referral of a patient. (May 25, 1989)
- Response from FTC Staff to the Department of Licensing and Regulations, Bureau of Health Services, State of Michigan, concerning proposed changes in the rules of the Michigan Board of Optometry (March 2, 1989)
- Response from FTC Staff to The Honorable Ray Hamlett, Missouri House of Representatives, concerning House Bill 320, which would prohibit any physical therapist from accepting wages or any other form of payment from any who refer patients to the therapist (February 27, 1989)
- Comments from FTC Staff to the Department of Health and Human Services, concerning regulations pursuant to the Medicare and Medicaid Anti-Kickback Statute (December 18, 1987)
- Response from FTC Staff to the Idaho State Board of Chiropractic Physicians, concerning proposed amendments to the rules of the Idaho State Board of Chiropractic Physicians (December 7, 1987)
- Response from FTC Staff to the Virginia Commission on Medical Care Facilities Certificate of Public Need concerning reform of certificate of public need regulation of health facilities (August 6, 1987)
- Response from FTC Staff to the New Jersey State Board of Dentistry concerning advertising regulations (July 14, 1987)
- Comments from FTC Staff to The Honorable Chuck Hardwick, Speaker of the Assembly of the State of New Jersey, concerning Assembly Bill 2647, which would prevent a physician from having a financial interest in any entity that provides physical therapy services, and from referring patients for physical therapy to an entity in which the physician’s family has any financial interest (May 21, 1987)
- Response from FTC Staff to The Honorable John A Lynch, Majority Leader, New Jersey Senate, concerning Senate Bill No. 1367, which would permit opticians to fit contact lenses provided that they first obtain certification as contact lens dispensers from the state board of opticians (May 14, 1987)
- Response from FTC Staff to The Honorable Harry Hill, State Representative of Missouri, concerning bills to regulate advertising by dentists (May 13, 1987)
- Response from FTC Staff to The Assembly of the State of New York concerning proposed legislation relating to lenses used for simple magnification, including ready-to-wear reading eyeglasses (May 11, 1987)
- Response from FTC Staff to The Honorable Tim Leslie, California Assembly, concerning Assembly Bill No. 1732, which would place certain restrictions on the ability of physicians to dispense prescription drugs to their patients (May 1, 1987)
- Response from FTC Staff to the Tennessee Board of Dentistry concerning the scope of permissible advertising by dentists (April 30, 1987)
- Response from FTC Staff to the Virginia State Board of Dentistry concerning final regulations proposed by the Board (April 23, 1987)
- Comments from FTC Staff to the Florida Board of Dentistry concerning proposed regulations restricting dental advertising (April 23, 1987)
- Response from FTC Staff to the South Carolina Legislative Audit Council concerning the sunset review of the laws governing, and regulations implemented by, the South Carolina State Boards of Podiatry Examiners, Occupational Therapy Examiners, Speech and Audiology Examiners, and Psychology Examiners (April 23, 1987)
- Response from FTC Staff to the Health Systems Agency of New York City, concerning its draft Medical Facilities Plan (February 9, 1987)
- Response from FTC Staff to the Maryland State Board of Medical Examiners, concerning the practice and regulation of the dispensing of prescription drugs by physicians (December 31, 1986)
- Response from FTC Staff to the State Examining Boards, State of Georgia, concerning rules proposed by the Georgia State Board of Pharmacy with respect to the dispensing of prescription drugs by physicians and certain other health care practitioners (November 26, 1986)
- Response from FTC Staff to the Commissioner of Insurance, State of Nevada, concerning the use of exclusive contracts by health maintenance organizations (November 5, 1986)
- Response from FTC Staff to the Deputy Attorney General, State of Nevada, concerning regulation proposed by the Nevada State Board of Physical Therapy (October 23, 1986)
- Comments from FTC Staff to the Department of Health and Human Services, concerning alternate systems for determining the maximum level of federal funding for state reimbursement of retail pharmacies for drugs dispensed to Medicaid customers (October 20, 1986)
- Response from FTC Staff to Mr. Owen H. Yamasaki, Office of the Auditor, Honolulu, Hawaii, concerning the sunset review of statutory provisions prohibiting certain business practices by optometrists (August 21, 1986)
- Response from FTC Staff to the Mississippi State Board of Optometry, concerning the proposed amendments to the advertising rules (July 10, 1986)
- Response from FTC Staff to the Honorable Emile Jones, Jr., the Illinois State Senate, concerning group contracting by physicians (June 11, 1986)
- Testimony of FTC Staff before the Committee on Regulatory Reform, Florida House of Representatives, concerning the sunset review of the Florida Optometry Act (April 30, 1986)
- Response from FTC Staff to the Virginia State Board of Optometry, concerning proposed regulations (April 15, 1986)
- Response from FTC Staff to the Virginia State Board of Dentistry, concerning proposed regulations (April 3, 1986)
- Comments of FTC Staff to the Council of the District of Columbia, concerning regulation of expanded role nurses (November 22, 1985)
- Response from FTC Staff to the Florida Board of Dentistry concerning disclosure of financial interests by referring dentists (November 6, 1985)
- Comments from FTC Staff to the Arizona State Board of Optometry concerning the Board’s proposed rules (October 17, 1985)
- Response from FTC Staff to the Attorney General of California concerning Assembly Bill 707, which would grant special treatment under the antitrust laws to health care providers, insurers, and purchasers for joint activities relating to contracts for the provision of health services (September 17, 1985)
- Response from FTC Staff to The Honorable Phillip Isenberg, California State Assembly, concerning Assembly Bill 1217, which would repeal existing restrictions on the number of branch offices that an optometrist or group of optometrists practicing in California may permissibly operate; remove existing restrictions on the ability of optometrists and opticians to develop and use brand names; and remove many of the existing restrictions on business relationships between optometrists and opticians (June 21, 1985)
- Response from FTC staff to the Legislative Council of Delaware, Sunset Review Committee, concerning review of the Delaware State Board of Optometric Examiners, including comments concerning regulations that prohibit certain business practices (May 31, 1985)
- Response from FTC Staff to the Honorable Ralph L. Axselle, Chairman of the Governor’s Regulatory Reform Board of the Commonwealth of Virginia, concerning review of health professional regulatory boards by the Commonwealth of Virginia (May 22, 1985)
- Response from FTC Staff to the Honorable Strom Thurmond, Chairman of the Committee of the Judiciary, U.S. Senate, regarding Hon. Thurmond’s request fo the FTC’s views concerning S. 379, the “Health Care Cost Containment Act of 1985” (May, 21, 1985)
- Response from FTC Staff to the New Jersey State Board of Dentistry, commenting on the Board of Dentistry’s proposed rules (March 19, 1985)
- Response from FTC Staff to the North Dakota State Board of Optometry, concerning proposed regulations (February 14, 1985)
- Comments from FTC Staff to the Minnesota Board of Dentistry concerning proposed amendments to rules of the Board (1985)
- Comments from FTC Staff to the Board of Registration in Medicine of the Commonwealth of Massachusetts, regarding the role of competition in the delivery of health care services (December 14, 1984)
- FTC Testimony before New Jersey Senate Labor, Industry, and Professions Committee concerning restrictions on contact lens fitting (October 17, 1984)
- Response from FTC Staff to the Legislative Research Office, Legislative Administration Committee, State of Oregon, concerning the sunset review of the Oregon State Boards of Optometry and Dentistry (August 22, 1984)
- Response from FTC Staff to the Department of Health Regulatory Boards, Commonwealth of Virginia, concerning the regulatory review of the Virginia State Boards of Dentistry and Medicine (August 21, 1984)
- Response from FTC Staff to the U.S. Department of Health and Human Services, concerning proposed regulations implementing Section 114 of the Tax Equity and Fiscal Responsibility Act of 1982, requiring that Health Maintenance Organizations and Competitive Medical Plans must meet to enter into a Medicare contract with the Health Care Financing Administration and to qualify for Medicare reimbursement (July 9, 1984)
- Response from FTC Staff to the Honorable Art Agnos, California State Assembly, concerning Assembly Bill 3504, which repeals existing restrictions on the number of branch offices that an optometrist or group of optometrists practicing in California may permissibly operate (June 28, 1984)
- Statement of FTC Staff to the Committee on the Judiciary, United States Senate, concerning S. 2051, Health Care Cost Containment Act of 1984 (June 26, 1984)
- FTC Testimony before the Health Committee of the California State Assembly concerning the proposed repeal of California statutes that limit forms of commercial practice by optometrists (May 10, 1983)
- Comments from FTC Staff to the U.S. Department of Health and Human Services concerning proposed revisions to the Conditions of Participation for Hospitals in Medicare and Medicaid (March 7, 1983)
- Comments from FTC Staff to the Board for Licensing Health Care Facilities of the State of Tennessee concerning competition among physicians and other health care providers licensed by the States, including nurse midwives, nurse practitioners, and nurse anesthetists (1983)
| 2005 | 2004 |2003 | 2002 | 2001 | 2000 | 1999| 1998 | 1997| 1996 | 1995| 1994 | 1993
| 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983|
|
||||